N@N

Joon Lee Maintained (ADVM) at Strong Buy and Held Target at $60 on, May 15th, 2024

Joon Lee of Truist Securities, Maintained "Adverum Biotechnologies, Inc." (ADVM) at Strong Buy and Held Target at $60 on, May 15th, 2024.

Joon has made no other calls on ADVM in the last 4 months.

There are 4 other peers that have a rating on ADVM. Out of the 4 peers that are also analyzing ADVM, 1 agrees with Joon's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $20 on, Tuesday, March 19th, 2024

These are the ratings of the 3 analyists that currently disagree with Joon

---

• Matthew Caufield of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $30 on, Friday, May 10th, 2024
• Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $22 on, Monday, April 29th, 2024
• Daniil Gataulin of "Chardan Capital" Reiterated at Strong Buy with Increased Target to $40 on, Tuesday, March 19th, 2024

Contributing Sources

---